Tag: Cordis

Cordis launches Mynx Control vascular closure device in the USA

Cordis, a Cardinal Health company, has launched its Mynx Control vascular closure device onto the US market. A press release reports that the Mynx...

First US commercial implants of Elunir drug-eluting stent performed

Cordis and Medinol have announced that the first US commercial cases using the Elunir drug-eluting stent have taken place at New York-Presbyterian Hospital/Columbia University...

Elunir drug-eluting stent approved for use in the USA

Cordis and Medinol have announced that the US FDA has approval the Elunir drug-eluting stent for the treatment of patients with coronary artery disease....

Cordis granted CE mark for Railway sheathless access system

Cordis has received the CE mark for its new Railway sheathless access system, which is now available in select countries across Europe. Railway is...

First US commercial case performed using Tryton Side branch stent

Tryton Medical has announced that the first US commercial case using the Tryton Side branch stent to treat a coronary bifurcation lesion involving a...

FDA grants approval to Tryton for side-branch stent

The US Food and Drug Administration (FDA) has approved Tryton Medical’s Premarket Approval (PMA) application for the Tryton side-branch stent for the treatment of...